title: CpG-DNA derived from sera in systemic lupus erythematosus enhances ICAM-1 expression on endothelial cells.
abstract: OBJECTIVE
  To examine the effect of transfection of oligodeoxynucleotides (ODNs) containing a CpG motif (CpG-ODN), of which the sequence was derived from circulating DNA in the sera of patients with systemic lupus erythematosus (SLE), on the expression of intercellular adhesion molecule-1 (ICAM-1) and synthesis of mRNA for proinflammatory cytokines and ICAM-1 in human umbilical vein endothelial cells (EC).
  
  
  METHODS
  A CpG-ODN or a control analogue, GpC-ODN, was transfected into EC. ICAM-1 expression was examined by flow cytometry, and expression of mRNA in EC encoding interleukin 1 (IL1), IL6, IL8, tumour necrosis factor alpha (TNFalpha), interferon gamma (IFNgamma), and ICAM-1 was examined by semiquantitative reverse transcriptase-polymerase chain reaction.
  
  
  RESULTS
  The CpG-ODN augmented the expression of ICAM-1 on EC determined by flow cytometry and increased mRNA levels of IL6, IL8, TNFalpha, IFNgamma, and ICAM-1, but the GpC-ODN did not.
  
  
  CONCLUSIONS
  Synthesised DNA, with a sequence corresponding to that of the fragment containing the CpG motif, in sera of patients with SLE was found to enhance ICAM-1 expression on EC, suggesting the participation of circulating DNA fragments in the pathogenesis of vasculitis in SLE.
authors.affiliation: Department of Internal Medicine II, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima City, Fukushima 960-1295, Japan. metm@msg.biglobe.ne.jp
authors.forename: M
authors.initials: M
authors.lastname: Miyata
authors.forename: O
authors.initials: O
authors.lastname: Ito
authors.forename: H
authors.initials: H
authors.lastname: Kobayashi
authors.forename: T
authors.initials: T
authors.lastname: Sasajima
authors.forename: H
authors.initials: H
authors.lastname: Ohira
authors.forename: S
authors.initials: S
authors.lastname: Suzuki
authors.forename: R
authors.initials: R
authors.lastname: Kasukawa
mesh_terms: D002478:Cells, Cultured; D018899:CpG Islands; D004247:DNA / Q000378:metabolism*; D004730:Endothelium, Vascular / Q000276:immunology*; D005229:Fatty Acids, Monounsaturated / Q000494:pharmacology; D005434:Flow Cytometry; D005456:Fluorescent Dyes / Q000494:pharmacology; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000235:genetics / Q000378:metabolism*; D007371:Interferon-gamma / Q000235:genetics; D007375:Interleukin-1 / Q000235:genetics; D015850:Interleukin-6 / Q000235:genetics; D016209:Interleukin-8 / Q000235:genetics; D008180:Lupus Erythematosus, Systemic / Q000235:genetics* / Q000276:immunology; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D012333:RNA, Messenger / Q000032:analysis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics
chemical_list: D005229:Fatty Acids, Monounsaturated; D005456:Fluorescent Dyes; D007375:Interleukin-1; D015850:Interleukin-6; D016209:Interleukin-8; D000644:Quaternary Ammonium Compounds; D012333:RNA, Messenger; D014409:Tumor Necrosis Factor-alpha; D018799:Intercellular Adhesion Molecule-1; D007371:Interferon-gamma; D004247:DNA; C070046:1,2-dioleoyloxy-3-(trimethylammonium)propane